James Hardie Industries Plc - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by James Hardie Industries Plc, a foreign private issuer, for the month of June 2018. The report was signed on June 7, 2018, by Natasha Mercer, Company Secretary. The filing primarily serves to distribute an Investor Roadshow Presentation (Exhibit 99.1) conducted in June 2018.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. This document acts as a cover for an external presentation and contains no embedded financial tables or operational results.
Material Changes
No material changes to financial performance or operations are detailed within the text of this filing. The document references the integration of Fermacell into the business as a risk factor but does not quantify the impact of this integration in this specific report.
Guidance, Outlook, and Risks
The filing contains extensive forward-looking statements and risk disclosures. Key areas of uncertainty and risk identified include:
- Asbestos Liabilities: Risks related to the Asbestos Injuries Compensation Fund (AICF), including contribution shortfalls and currency exchange impacts on recorded liabilities.
- Legal and Regulatory: Exposure to product liability, environmental, and consumer class action proceedings.
- Market Conditions: Dependence on US and Asia Pacific housing markets, new home construction levels, and consumer confidence.
- Operational Risks: Costs associated with plant closures or capital expenditure projects, and the integration of the Fermacell acquisition.
- Financial Risks: Currency exchange rates, raw material costs, and the ability to renew credit facilities on favorable terms.
Management cautions that actual results may differ materially from projections due to these inherent risks.
Investor Verification Checklist
- Review the attached "Investor Roadshow Presentation - June 2018" (Exhibit 99.1) for specific financial guidance and operational metrics not included in this cover filing.
- Verify the current status and funding adequacy of the Asbestos Injuries Compensation Fund (AICF).
- Monitor updates on the integration progress and financial impact of the Fermacell acquisition.
- Assess current housing market trends in the US and Asia Pacific regions to gauge demand drivers.
- Check for any new developments in pending legal proceedings or regulatory audits mentioned in the risk factors.